{
    "code": "60000963",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=60000963",
    "time": "2020-02-26 09:58:40",
    "許可證字號": "衛部菌疫輸字第000963號",
    "註銷狀態": "已註銷",
    "註銷日期": "107\/10\/19",
    "註銷理由": "自請註銷",
    "有效日期": "108\/09\/01",
    "發證日期": "103\/09\/01",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA06000096300",
    "中文品名": "亞舍拉注射劑",
    "英文品名": "Arzerra concentrate for solution for Infusion",
    "適應症": "治療對含fludarabine治療無效的CD20陽性慢性淋巴球性白血病(CLL)患者",
    "劑型": "270注射劑",
    "包裝": "100mg\/5mL及1000mg\/50mL小瓶裝,100小瓶以下盒裝盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入 51免除銜接性臨床試驗",
        "申請商名稱": "0924601100  台灣諾華股份有限公司",
        "申請商地址": "台北市中山區民生東路三段2號8樓",
        "主製造廠": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "FUS0508000  LONZA BIOLOGICS, INC.",
            "製造廠廠址": "101 INTERNATIONAL DRIVE PEASE INTERNATIONAL TRADEPORT PORTSMOUTH, NEW HAMPSHIRE, U.S. 03801",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "原料藥製造廠"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013004200",
            "成分名稱": "Ofatumumab",
            "含量描述": "",
            "含量": "20.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "衛部菌疫輸字第000963號-亞舍拉注射劑-仿單(英文)-106-11-10.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000963&Seq=002&Type=9"
        },
        {
            "title": "衛部菌疫輸字第000963號-亞舍拉注射劑-仿單(中文)-106-11-10.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000963&Seq=001&Type=9"
        },
        {
            "title": "020009630005-103-10-09.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000963&Seq=006&Type=8"
        }
    ]
}